157 related articles for article (PubMed ID: 11126208)
1. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Molnár D; Török K; Erhardt E; Jeges S
Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1573-8. PubMed ID: 11126208
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
Toubro S; Astrup AV; Breum L; Quaade F
Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S69-72. PubMed ID: 8384186
[TBL] [Abstract][Full Text] [Related]
3. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
Astrup A; Breum L; Toubro S; Hein P; Quaade F
Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
[TBL] [Abstract][Full Text] [Related]
4. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
Breum L; Pedersen JK; Ahlstrøm F; Frimodt-Møller J
Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931
[TBL] [Abstract][Full Text] [Related]
5. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
Toubro S; Astrup A; Breum L; Quaade F
Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S73-7; discussion S82. PubMed ID: 8124407
[TBL] [Abstract][Full Text] [Related]
6. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
Boozer CN; Daly PA; Homel P; Solomon JL; Blanchard D; Nasser JA; Strauss R; Meredith T
Int J Obes Relat Metab Disord; 2002 May; 26(5):593-604. PubMed ID: 12032741
[TBL] [Abstract][Full Text] [Related]
7. Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
Daly PA; Krieger DR; Dulloo AG; Young JB; Landsberg L
Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S73-8. PubMed ID: 8384187
[TBL] [Abstract][Full Text] [Related]
8. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
Coffey CS; Steiner D; Baker BA; Allison DB
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1411-9. PubMed ID: 15356670
[TBL] [Abstract][Full Text] [Related]
9. The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.
Astrup A; Buemann B; Christensen NJ; Toubro S; Thorbek G; Victor OJ; Quaade F
Metabolism; 1992 Jul; 41(7):686-8. PubMed ID: 1619985
[TBL] [Abstract][Full Text] [Related]
10. Is an ephedrine caffeine treatment contraindicated in hypertension?
Ingerslev J; Svendsen TL; Mørk A
Int J Obes Relat Metab Disord; 1997 Aug; 21(8):666-73. PubMed ID: 15481766
[TBL] [Abstract][Full Text] [Related]
11. Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females.
Bracale R; Petroni ML; Davinelli S; Bracale U; Scapagnini G; Carruba MO; Nisoli E
PLoS One; 2014; 9(6):e98244. PubMed ID: 24905629
[TBL] [Abstract][Full Text] [Related]
12. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
Buemann B; Marckmann P; Christensen NJ; Astrup A
Int J Obes Relat Metab Disord; 1994 May; 18(5):329-32. PubMed ID: 8061726
[TBL] [Abstract][Full Text] [Related]
13. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
Hackman RM; Havel PJ; Schwartz HJ; Rutledge JC; Watnik MR; Noceti EM; Stohs SJ; Stern JS; Keen CL
Int J Obes (Lond); 2006 Oct; 30(10):1545-56. PubMed ID: 16552410
[TBL] [Abstract][Full Text] [Related]
14. The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss.
Liu AG; Smith SR; Fujioka K; Greenway FL
Obesity (Silver Spring); 2013 Oct; 21(10):1991-6. PubMed ID: 23686786
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects of ephedrine in the treatment of obesity.
Pasquali R; Casimirri F
Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S65-8. PubMed ID: 8384185
[No Abstract] [Full Text] [Related]
16. [The effect of an ephedrine/caffeine combination as a supplement to a weight-reducing diet. A randomized, placebo-controlled, double-blind trial].
Quaade F; Astrup A; Breum L; Toubro S; Hein P
Ugeskr Laeger; 1992 Apr; 154(18):1258-63. PubMed ID: 1598695
[No Abstract] [Full Text] [Related]
17. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
[TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent.
Greenway FL
Obes Rev; 2001 Aug; 2(3):199-211. PubMed ID: 12120105
[TBL] [Abstract][Full Text] [Related]
19. Ephedrine as an anorectic: the story of the 'Elsinore pill'.
Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
Int J Obes; 1981; 5(2):183-7. PubMed ID: 7228474
[TBL] [Abstract][Full Text] [Related]
20. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine.
Ramsey JJ; Colman RJ; Swick AG; Kemnitz JW
Am J Clin Nutr; 1998 Jul; 68(1):42-51. PubMed ID: 9665095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
